J&J buys EIT for 3D-printed titanium spinal implants

The devices are designed to increase the number of surgeries that are successful the first time.

By Nick Paul Taylor • Sept. 13, 2018

UK-based Medopad snaps up health IT startup Sherbit

Founded in 2016, Sherbit works with health systems on chronic disease management using real-time data and analytics.

By Meg Bryant • Sept. 12, 2018

Alcon to shift HQ to Switzerland after Novartis spinoff

The eye care unit already has operations in Geneva, and plans to list on Swiss stock exchanges upon becoming a standalone company. 

By Ned Pagliarulo • Sept. 11, 2018

Stryker buys surgical lighting company for $190M

Photonics and intracavity lighting company Invuity is the latest acquisition in Stryker's ongoing purchasing spree.

By Rebecca Pifer • Sept. 11, 2018

Becton Dickinson sells bioprocessing business to Thermo Fisher

Divesting the unit will allow Becton to better focus its life sciences division on disease and therapy research and clinical diagnostics.

By Susan Kelly • Sept. 10, 2018

Biotech billionaire Phillip Frost charged by SEC, sending Opko shares sliding

The SEC announced the charges Friday, alleging the Opko CEO and nine others manipulated stock prices in "classic pump-and-dump schemes."

By Andrew Dunn • Updated Sept. 8, 2018

BTG acquires Irish device maker Novate Medical

The $20 million cash deal could reach $150 million if certain business milestones are met.

By David Lim • Sept. 7, 2018

Boston Scientific inks $600M Augmenix buyout

The focus of the deal is a device to reduce the side effects of prostate cancer radiotherapy.

By Nick Paul Taylor • Sept. 7, 2018

Amazon's stock valuation hits $1T

The e-tailer and tech company is still far behind its primary rivals in terms of profitability, but its explosive growth has wowed investors, who show no signs of losing faith in Amazon's future.

By Ben Unglesbee • Sept. 5, 2018

Stryker buys spine device maker K2M for $1.4B

The acquisition is expected to give Stryker some needed heft in the category, adding several differentiated products in faster-growth areas of the specialty.

By Susan Kelly • Aug. 31, 2018

Wright Medical inks $435M takeover of implant firm Cartiva

An arthritis implant with fast-growing sales is the focal point of the acquisition.

By Nick Paul Taylor • Aug. 28, 2018

Robotic surgery market is about to get crowded, report says

GlobalData predicts larger companies will accelerate investment in surgical robotics through acquisitions and partnerships.

By Susan Kelly • Aug. 24, 2018

Pfizer inks marketing deal for Exact's Cologuard

Exact said about 401,000 tests were performed during the first six months of 2018, leading to revenue of $193 million. The CEO now expects $700 million in sales for next year.

By Andrew Dunn • Aug. 22, 2018

Healthcare execs see Amazon as biggest disrupter

Apple and Google were among those also feared, though Amazon held a giant lead in the survey, according to a report from Reaction Data.

By Meg Bryant • Aug. 22, 2018

AngioDynamics buys biopsy sealant technology from Surgical Specialties

The acquisition will expand the company’s portfolio of oncology devices.

By Nick Paul Taylor • Aug. 16, 2018

Boston Scientific inks Veniti takeover to access untapped stent market

The $160 million buy moves the company into the nascent venous stent sector.

By Nick Paul Taylor • Aug. 9, 2018

Varian acquires maker of patient monitoring system

The radiation therapy company said the buy expands its motion-management portfolio, part of its cancer care strategy.

By Susan Kelly • Aug. 7, 2018

AI-based medical imaging market on track to hit $2B by 2023

Major applications are expected in neurology and cardiovascular disease detection and diagnosis, according to a report from Signify Research.

By Meg Bryant • Aug. 3, 2018

Drugs make up more US health spending than thought, report suggests

Research published in Health Affairs finds drugs accounted for 15% of total U.S. healthcare spending in 2016, higher than the oft-cited 10% figure.

By Ned Pagliarulo • Aug. 3, 2018

Cerner bookings, revenue see strong growth in Q2

Seven large transactions contributed more than $75 million to bookings, with Cerner President Zane Burke calling the deals "a full box of chocolates ... all very desirable." 

By Meg Bryant • Aug. 3, 2018

Bio-Techne closes $250M Exosome Diagnostics takeover

The acquisition moves the company into the nascent liquid biopsy sector.

By Nick Paul Taylor • Aug. 3, 2018

Hologic buys Faxitron for $85M to expand breast cancer business

The takeover moves Hologic deeper into the breast conserving surgery market.

By Nick Paul Taylor • Aug. 2, 2018

CSI, Aerolase partner on laser atherectomy device

St. Paul, Minnesota-based CSI competes in the market against much bigger players including Medtronic, Boston Scientific and Phillips.

By Susan Kelly • Aug. 1, 2018

Stryker says Q2 tops goals, will stick to M&A playbook

The device maker boasted of strong demand for its robot for knee surgery but said its spine business remained "challenged."

By Susan Kelly • July 25, 2018

Quest Diagnostics posts slight Q2 revenue miss

CEO Stephen Rusckowski said the company welcomes CMS' recent proposal to change how it collects clinical laboratory fee data.

By Susan Kelly • July 24, 2018